Aethlon Medical Inc (NASDAQ:AEMD) currently has a daily average trading volume of 1.83M but it saw 8663806 shares traded in last market. With a market cap of 5.44M USD, the company’s current market price of $0.39 came rising about 8.82 while comparing to the previous closing price of $0.36. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.69 and as low as $0.24. In the recent trading on the day, stock has struck highest price mark of $0.3615 while lowest mark touched by it was $0.41.
Taking a look at 20-day trading activity of Aethlon Medical Inc (AEMD) gives us an average price of $0.4076, while its current price level is -85.48% below from 52-week high level whereas it is 64.21% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3891 while that of 200 days or SMA-200 reads an average of $1.1588. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.41% during that period while stretching the period over a month that increases to 13.97%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 49.45 which implies that the stock is in neutral territory.
Over the week, AEMD’s stock price is moving -1.02% down while it is -16.07% when we observe its performance for the past one month. Year-to-date it is -82.19% down and over the past year, the stock is showing a downside performance of -84.55%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -1.22 beat the consensus estimate of -1.4 for the same. The company is expected to be releasing its next quarterly report in October, for which analysts forecasted an EPS of -0.19 while estimate for next year EPS is -1.02.
Currently, Aethlon Medical Inc’s total number of outstanding shares is 13.94M. Company’s return on investment (ROI) stands at -123.81% and return on equity (ROE) at -105.38%. Stock’s beta reads 1.74. Stock has a price to book (P/B) ratio of 0.62. Its return on asset (ROA) is -84.49% on average.
